• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低密度脂蛋白免疫可诱导T细胞依赖性抗体形成并预防动脉粥样硬化。

LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis.

作者信息

Zhou X, Caligiuri G, Hamsten A, Lefvert A K, Hansson G K

机构信息

Centre for Molecular Medicine and King Gustaf V Research Institute, Karolinska Institutet, Stockholm, Sweden.

出版信息

Arterioscler Thromb Vasc Biol. 2001 Jan;21(1):108-14. doi: 10.1161/01.atv.21.1.108.

DOI:10.1161/01.atv.21.1.108
PMID:11145941
Abstract

Atherosclerosis is an inflammatory disease, and the involvement of immune mechanisms in disease progression is increasingly recognized. Immunization with oxidized low density lipoprotein (LDL) decreases atherosclerosis in several animal models. To explore humoral and cellular immune reactions involved in this protection, we immunized apolipoprotein E knockout mice with either homologous plaque homogenates or homologous malondialdehyde (MDA)-LDL. Immunization with both these antigen preparations reduced lesion development. The plaques contained immunogen(s) sharing epitopes on MDA-LDL, MDA-very low density lipoprotein, and oxidized cardiolipin. This shows that a T-cell-dependent antibody response was associated with protection against atherosclerosis. The protection was associated with specific T-cell-dependent elevation of IgG antibodies against MDA-LDL and oxidized phospholipids, and the increased titers of IgG antibodies were correlated with decreased lesion formation and lower serum cholesterol levels.

摘要

动脉粥样硬化是一种炎症性疾病,免疫机制在疾病进展中的作用越来越受到认可。在几种动物模型中,用氧化型低密度脂蛋白(LDL)进行免疫可减轻动脉粥样硬化。为了探究这种保护作用中涉及的体液免疫和细胞免疫反应,我们用同源斑块匀浆或同源丙二醛(MDA)-LDL对载脂蛋白E基因敲除小鼠进行免疫。用这两种抗原制剂进行免疫均可减少病变发展。这些斑块含有在MDA-LDL、MDA-极低密度脂蛋白和氧化型心磷脂上具有共同表位的免疫原。这表明T细胞依赖性抗体反应与抗动脉粥样硬化保护作用相关。这种保护作用与针对MDA-LDL和氧化磷脂的IgG抗体的特异性T细胞依赖性升高有关,并且IgG抗体滴度的增加与病变形成减少和血清胆固醇水平降低相关。

相似文献

1
LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis.低密度脂蛋白免疫可诱导T细胞依赖性抗体形成并预防动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2001 Jan;21(1):108-14. doi: 10.1161/01.atv.21.1.108.
2
Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes.用同源丙二醛修饰的和天然低密度脂蛋白对低密度脂蛋白受体缺陷小鼠进行免疫接种,通过诱导针对氧化新表位的高滴度抗体以外的机制降低动脉粥样硬化的进展。
Arterioscler Thromb Vasc Biol. 1998 Dec;18(12):1972-82. doi: 10.1161/01.atv.18.12.1972.
3
Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.病变发展及对免疫的反应揭示了CD4在动脉粥样硬化中具有复杂作用。
Circ Res. 2005 Mar 4;96(4):427-34. doi: 10.1161/01.RES.0000156889.22364.f1. Epub 2005 Jan 20.
4
Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis.抗醛修饰载脂蛋白B-100肽序列的重组人抗体可抑制动脉粥样硬化。
Circulation. 2004 Oct 5;110(14):2047-52. doi: 10.1161/01.CIR.0000143162.56057.B5. Epub 2004 Sep 27.
5
IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis.白细胞介素-5将针对氧化型低密度脂蛋白表位的适应性免疫和天然免疫联系起来,并预防动脉粥样硬化。
J Clin Invest. 2004 Aug;114(3):427-37. doi: 10.1172/JCI20479.
6
Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis.用丙二醛修饰的低密度脂蛋白(LDL)进行免疫可减轻感染牙龈卟啉单胞菌的低密度脂蛋白受体缺陷小鼠的动脉粥样硬化。
Innate Immun. 2015 May;21(4):370-85. doi: 10.1177/1753425914542444. Epub 2014 Aug 17.
7
Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis.用同源丙二醛低密度脂蛋白对载脂蛋白E缺乏小鼠进行超免疫可抑制早期动脉粥样硬化的发生。
Atherosclerosis. 1998 May;138(1):147-52. doi: 10.1016/s0021-9150(98)00015-x.
8
Immunization with gingipain A hemagglutinin domain of Porphyromonas gingivalis induces IgM antibodies binding to malondialdehyde-acetaldehyde modified low-density lipoprotein.牙龈卟啉单胞菌牙龈蛋白酶A血凝素结构域免疫可诱导产生与丙二醛-乙醛修饰的低密度脂蛋白结合的IgM抗体。
PLoS One. 2018 Jan 12;13(1):e0191216. doi: 10.1371/journal.pone.0191216. eCollection 2018.
9
The pro-inflammatory effect of uraemia overrules the anti-atherogenic potential of immunization with oxidized LDL in apoE-/- mice.尿毒症的促炎作用超过了用氧化型 LDL 免疫 apoE-/- 小鼠的抗动脉粥样硬化作用。
Nephrol Dial Transplant. 2010 Aug;25(8):2486-91. doi: 10.1093/ndt/gfq059. Epub 2010 Feb 17.
10
Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences.通过用载脂蛋白B-100肽序列免疫来抑制载脂蛋白E基因敲除小鼠的动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):879-84. doi: 10.1161/01.ATV.0000067937.93716.DB. Epub 2003 Mar 20.

引用本文的文献

1
Atherosclerosis: from lipid-lowering and anti-inflammatory therapies to targeting arterial retention of ApoB-containing lipoproteins.动脉粥样硬化:从降脂和抗炎疗法到靶向含载脂蛋白B脂蛋白的动脉潴留
Front Immunol. 2025 Jun 9;16:1485801. doi: 10.3389/fimmu.2025.1485801. eCollection 2025.
2
Dendritic cells immunotargeted therapy for atherosclerosis.树突状细胞免疫靶向治疗动脉粥样硬化
Acta Pharm Sin B. 2025 Feb;15(2):792-808. doi: 10.1016/j.apsb.2024.12.029. Epub 2024 Dec 31.
3
Vaccination as a Promising Approach in Cardiovascular Risk Mitigation: Are We Ready to Embrace a Vaccine Strategy?
接种疫苗作为减轻心血管风险的一种有前景的方法:我们准备好接受疫苗策略了吗?
Biomolecules. 2024 Dec 20;14(12):1637. doi: 10.3390/biom14121637.
4
A bibliometric analysis of immunotherapy for atherosclerosis: trends and hotspots prediction.动脉粥样硬化免疫治疗的文献计量分析:趋势与热点预测
Front Immunol. 2024 Nov 19;15:1493250. doi: 10.3389/fimmu.2024.1493250. eCollection 2024.
5
Atherosclerosis antigens as targets for immunotherapy.动脉粥样硬化抗原作为免疫治疗的靶点。
Nat Cardiovasc Res. 2023 Dec;2(12):1129-1147. doi: 10.1038/s44161-023-00376-x. Epub 2023 Dec 11.
6
Serum immunoglobulin M is associated with the severity of coronary artery disease in adults.血清免疫球蛋白M与成人冠状动脉疾病的严重程度相关。
PeerJ. 2024 Mar 5;12:e17012. doi: 10.7717/peerj.17012. eCollection 2024.
7
Two decades of vaccine development against atherosclerosis.针对动脉粥样硬化的疫苗研发二十年。
Nano Today. 2023 Jun;50. doi: 10.1016/j.nantod.2023.101822. Epub 2023 Mar 31.
8
Circulating Regulatory B-Lymphocytes in Patients with Acute Myocardial Infarction: A Pilot Study.急性心肌梗死患者循环调节性B淋巴细胞的初步研究
J Cardiovasc Dev Dis. 2022 Dec 22;10(1):2. doi: 10.3390/jcdd10010002.
9
Positive Association between Autoantibodies Against Oxidized LDL and HDL-C: A Novel Mechanism for HDL Cardioprotection?抗氧化型低密度脂蛋白自身抗体与高密度脂蛋白胆固醇之间的正相关关系:高密度脂蛋白心脏保护作用的一种新机制?
Arq Bras Cardiol. 2022 Sep 2;119(5):714-21. doi: 10.36660/abc.20210796.
10
Modulating Autoimmunity against LDL: Development of a Vaccine against Atherosclerosis.调节针对 LDL 的自身免疫:动脉粥样硬化疫苗的开发。
Hamostaseologie. 2021 Dec;41(6):447-457. doi: 10.1055/a-1661-1908. Epub 2021 Dec 23.